HSP 58.66 Hospira Inc $HSP Hit a 52 week high of 5
Post# of 74540
Posted On: 11/18/2014 11:08:04 AM
HSP 58.66 Hospira Inc $HSP Hit a 52 week high of 58.68 Closing the day 09:43 at 58.66 +0.26 +0.45% With a day low of 58.13 and a total volume of 23,607.
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Earnings Look Back: Hospira Is Up 2.9% Since Reporting Quarterly Results 1 Week Ago (HSP)
Comtex SmarTrend(R) - Mon Nov 17, 11:31AM CST
When Hospira (NYSE:HSP) reported earnings a week ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.54 on sales of $1.1 billion. Hospira actually reported earnings of $0.74 per share on sales of $1.2 billion, beating EPS estimates by $0.20 and beating revenue estimates by $68.6 million. Shares of Hospira have climbed from $56.64 to $58.28, representing a gain of 2.9% since the company reported earnings 11 days ago.
HSP: 59.29 (+0.89)
Hospira Mourns Passing of Founding Board Member Dr. Connie R. Curran
PR Newswire - Mon Nov 17, 9:30AM CST
The board of directors and employees of Hospira, Inc. (NYSE: HSP) today expressed their deepest sorrow over the loss of Connie R. Curran, R.N., Ed. D, one of the company's founding board members. Dr. Curran had served as a member of the Hospira Board since 2004, providing invaluable contributions to the business through her strategic leadership, exceptional command of the healthcare industry and shared passion for the company's commitment to putting patients first.
HSP: 59.29 (+0.89)
Hospira Has Returned 11.8% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - Fri Nov 14, 10:02AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 3 weeks, Hospira has returned 11.79% as of today's recent price of $57.95.
HSP: 59.29 (+0.89)
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 143.57 (+1.52), ACT: 260.20 (+12.26), CBG: 32.84 (+0.32), HCP: 44.11 (-0.06), BCR: 166.87 (+2.06), PCG: 50.59 (+0.01), AMGN: 160.10 (+0.96), CB: 102.01 (+0.46), SRE: 110.39 (+0.41), PLD: 41.12 (+0.11), HSP: 59.29 (+0.89), TWX: 80.04 (-0.36), KIM: 24.85 (+0.10), CMI: 144.55 (-0.23), ALXN: 190.26 (+3.48), ESS: 200.96 (+0.44), ABBV: 65.70 (+0.66), CAT: 101.46 (-0.24), AAPL: 114.50 (+0.51)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 3.20 (+0.77), JNJ: 109.00 (+0.70), IDRA: 2.41 (+0.03), DERM: 16.16 (+0.19), MRK: 59.72 (+0.26), PFE: 30.51 (+0.19), AZN: 73.34 (+0.84), AMGN: 160.10 (+0.96), GSK: 46.18 (+0.30), HSP: 59.29 (+0.89), NVS: 95.44 (+1.06), CELG: 106.46 (+2.10)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 59.29 (+0.89)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.55 (+0.06), WFM: 48.05 (+0.64), TSLA: 258.88 (+4.90), LEN: 45.64 (unch), QCOM: 70.72 (+0.32), PHM: 20.98 (+0.01), TOL: 33.86 (+0.02), GNW: 9.36 (+0.03), HSP: 59.29 (+0.89)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 86.64 (+0.94), ABAX: 54.94 (+0.28), GWPH: 78.65 (+2.09), HSP: 59.29 (+0.89)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 59.29 (+0.89)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 59.29 (+0.89)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 212.01 (+2.81), ABAX: 54.94 (+0.28), ABBV: 65.70 (+0.66), HSP: 59.29 (+0.89)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 59.29 (+0.89)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 59.29 (+0.89)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 59.29 (+0.89)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 59.29 (+0.89)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Earnings Look Back: Hospira Is Up 2.9% Since Reporting Quarterly Results 1 Week Ago (HSP)
Comtex SmarTrend(R) - Mon Nov 17, 11:31AM CST
When Hospira (NYSE:HSP) reported earnings a week ago on November 6th, 2014, analysts, on average, expected the company to report earnings of $0.54 on sales of $1.1 billion. Hospira actually reported earnings of $0.74 per share on sales of $1.2 billion, beating EPS estimates by $0.20 and beating revenue estimates by $68.6 million. Shares of Hospira have climbed from $56.64 to $58.28, representing a gain of 2.9% since the company reported earnings 11 days ago.
HSP: 59.29 (+0.89)
Hospira Mourns Passing of Founding Board Member Dr. Connie R. Curran
PR Newswire - Mon Nov 17, 9:30AM CST
The board of directors and employees of Hospira, Inc. (NYSE: HSP) today expressed their deepest sorrow over the loss of Connie R. Curran, R.N., Ed. D, one of the company's founding board members. Dr. Curran had served as a member of the Hospira Board since 2004, providing invaluable contributions to the business through her strategic leadership, exceptional command of the healthcare industry and shared passion for the company's commitment to putting patients first.
HSP: 59.29 (+0.89)
Hospira Has Returned 11.8% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - Fri Nov 14, 10:02AM CST
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 3 weeks, Hospira has returned 11.79% as of today's recent price of $57.95.
HSP: 59.29 (+0.89)
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 143.57 (+1.52), ACT: 260.20 (+12.26), CBG: 32.84 (+0.32), HCP: 44.11 (-0.06), BCR: 166.87 (+2.06), PCG: 50.59 (+0.01), AMGN: 160.10 (+0.96), CB: 102.01 (+0.46), SRE: 110.39 (+0.41), PLD: 41.12 (+0.11), HSP: 59.29 (+0.89), TWX: 80.04 (-0.36), KIM: 24.85 (+0.10), CMI: 144.55 (-0.23), ALXN: 190.26 (+3.48), ESS: 200.96 (+0.44), ABBV: 65.70 (+0.66), CAT: 101.46 (-0.24), AAPL: 114.50 (+0.51)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 3.20 (+0.77), JNJ: 109.00 (+0.70), IDRA: 2.41 (+0.03), DERM: 16.16 (+0.19), MRK: 59.72 (+0.26), PFE: 30.51 (+0.19), AZN: 73.34 (+0.84), AMGN: 160.10 (+0.96), GSK: 46.18 (+0.30), HSP: 59.29 (+0.89), NVS: 95.44 (+1.06), CELG: 106.46 (+2.10)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 59.29 (+0.89)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.55 (+0.06), WFM: 48.05 (+0.64), TSLA: 258.88 (+4.90), LEN: 45.64 (unch), QCOM: 70.72 (+0.32), PHM: 20.98 (+0.01), TOL: 33.86 (+0.02), GNW: 9.36 (+0.03), HSP: 59.29 (+0.89)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 86.64 (+0.94), ABAX: 54.94 (+0.28), GWPH: 78.65 (+2.09), HSP: 59.29 (+0.89)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 59.29 (+0.89)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 59.29 (+0.89)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 212.01 (+2.81), ABAX: 54.94 (+0.28), ABBV: 65.70 (+0.66), HSP: 59.29 (+0.89)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 59.29 (+0.89)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 59.29 (+0.89)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 59.29 (+0.89)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 59.29 (+0.89)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
(0)
(0)Scroll down for more posts ▼